반응식
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[NH2:17][C:18]1[CH:23]=[CH:22][C:21]([CH3:24])=[CH:20][CH:19]=1>>[CH3:24][C:21]1[CH:22]=[CH:23][C:18]([NH:17][C:1](=[O:10])[C:2]2[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=2)[OH:4])=[CH:19][CH:20]=1참가 물질
3
실험 절차
The 4′-methyl-salicylanilide was prepared by condensing phenyl salicylate with 4-toluidine then purified as described in Example 2a. A ligand mixture was then prepared from 4′-methyl-salicylanilide and binaphthol using the procedure described in Example 5a. 31P NMR (121.77 MHz): several peaks between 117.1-117.8 ppm.
후처리
- customthen purified
- customA ligand mixture was then prepared from 4′-methyl-salicylanilide and binaphthol using the procedure
출처 및 근거
- ORD 기록
- ord-fc21bdecdfb54a22b3196ecf9c212560
- 출처 데이터셋
- uspto-grants-2003_12
- 특허 번호
- US06664427B1
연결된 노트
불러오는 중…